Molina Healthcare – Key Facts for Investors

Shares of Health Care sector company Molina Healthcare moved -4.3% today, and are now trading at a price of $310.03. The Large-Cap stock's daily volume was 1,426,545 compared to its average volume of 389,545. The S&P 500 index returned a -1.0% performance.

Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. The company is based in Long Beach and has 18,000 full time employees. Its market capitalization is $18,162,735,104.

14 analysts are following Molina Healthcare and have set target prices ranging from $354.0 to $442.0 per share. On average, they have given the company a rating of hold. At today's prices, MOH is trading -22.68% away from its average analyst target price of $400.98 per share.

Over the last year, MOH's share price has increased by 18.3%, which represents a difference of -8.6% when compared to the S&P 500. The stock's 52 week high is $423.92 per share whereas its 52 week low is $266.35. With average free cash flows of $1.03 Billion that have been growing at an average rate of 149.0% over the last 5 years, Molina Healthcare is in a position to continue its strong stock performance trend.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2023 1,662,000 84,000 1,578,000 131.38
2022 773,000 91,000 682,000 -66.6
2021 2,119,000 77,000 2,042,000 11.95
2020 1,898,000 74,000 1,824,000 383.82
2019 434,000 57,000 377,000 209.59
2018 -314,000 30,000 -344,000
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.